Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway (Q28565300)

31 January 2017

title

Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway (English)

1 reference

31 January 2017

0 references

1 reference

Ying Meng

1

1 reference

31 January 2017

Chang-Hui Yu

2

1 reference

31 January 2017

Wei Li

3

1 reference

31 January 2017

Ting Li

4

1 reference

31 January 2017

Wei Luo

5

1 reference

31 January 2017

Shan Huang

6

1 reference

31 January 2017

Ping-Sheng Wu

7

1 reference

31 January 2017

Shao-Xi Cai

8

1 reference

31 January 2017

Xu Li

9

1 reference

31 January 2017

publication date

1 April 2014

1 reference

American Journal of Respiratory Cell and Molecular Biology

31 January 2017

published in

1 reference

31 January 2017

volume

50

1 reference

31 January 2017

issue

4

1 reference

31 January 2017

page(s)

723–736

1 reference

Pulmonary fibrosis: pathogenesis, etiology and regulation

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Treatment of idiopathic pulmonary fibrosis with losartan: a pilot project

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

ACE2: a new target for cardiovascular disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) as an antihypertensive, antifibrotic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

The role of nuclear factor-kappa B in pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogen-activated protein kinase and nuclear factor-[kappa] B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Cellular FLICE-like inhibitory protein deviates myofibroblast fas-induced apoptosis toward proliferation during lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Oral Angiotensin-(1-7) prevented obesity and hepatic inflammation by inhibition of resistin/TLR4/MAPK/NF-κB in rats fed with high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Simple method of estimating severity of pulmonary fibrosis on a numerical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Inhibition of human lung cancer cell growth by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Apoptosis in lung injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin-(1-7) attenuates high glucose-induced proximal tubular epithelial-to-mesenchymal transition via inhibiting ERK1/2 and p38 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC

Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2012-0451OC